MS decreases the larger amplitude distribution in adult rats. by Jesús David Ayala-Rodríguez (17364296)

Matrix crosslinking decreases cell migration persistence. by Michael Pamonag (12295175)

A noxious temperature decrease without a prior increase produces a subtly larger decrease in pain intensity. by Benedict J. Alter (9745466)

Correlations of cytokines that significantly change between the pre-infusion and post-infusion blood draws pearson’s correlation between cytokine pairs is indicated by color and si... by Jordan K. Abbott (8934239)

Subjects:

Bubble radiated power reduction vs. depth. by Mark W. Sprague (12220544)

Subjects:

Reductions in the variation of treatment costs for a given value after price negotiation. by Jing Zhou (168494)

Subjects:

Larger example of stimuli with cue relevant for Task 3. by Marcel F. Hinss (14675457)

Long COVID prevalence decreases with vaccine uptake in the U.S. by Manlio De Domenico (626037)

“…<p>(A) Prevalence in U.S. states and the U.S. exhibits a decreasing trend with respect to vaccine uptake, both in the population vaccinated with at least one dose (top) and two doses (bottom), with the largest gap between 100% vaccinated and 100% unvaccinated scenarios observed in the reference population of adults who had COVID-19. …”

Modelling the significance of prevalence reduction from pre- to post-intervention surveys. by Kareen Atekem (14290058)

Subjects:

Points represent regions where the cluster coefficient was significantly larger in HC compared to MCI, at sparsity level of 0.15. by Therese M. Gilligan (7460906)

Lab parameters–Significant reduction in means. by Harleen Kaur (288288)

“…Adjuvant homoeopathic medicines were given in the treatment group and SOC was given to both groups. …”

Decrease of injuries. by Petr Fulin (8380320)

Subjects:

Example of predicted effects of choice bundling on preference for larger, later rewards (LLRs) over smaller, sooner rewards (SSRs). by Jeffrey S. Stein (11689918)

Decrease of admissions and lead diagnoses. by Petr Fulin (8380320)

Subjects:

Sensitivity analyses of seroprevalence with the largest sample size study omitted. by Yu Zhou (89766)

Significant relationships between QOL measures on infusion day and day 7. by Jordan K. Abbott (8934239)

Subjects:

Phase 2 significant effects. by Wendy C. Crone (2262169)

Phase 1 significant effects. by Wendy C. Crone (2262169)

Percentage of improvement in Alzheimer severity scores after acetylcholinesterase inhibitors (AChEIs) medications were given to the patients. by Ramada R. Khasawneh (6837734)

Reduction of Nodule and mf prevalence. by Kareen Atekem (14290058)

Subjects: